Legacy Capital Partners’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $501K | Buy |
41,260
+1,660
| +4% | +$34.9K | 0.17% | 103 |
|
|
2021
Q4 | $1.35M | Hold |
39,600
| – | – | 0.44% | 64 |
|
|
2021
Q3 | $1.91M | Hold |
39,600
| – | – | 0.69% | 48 |
|
|
2021
Q2 | $1.79M | Hold |
39,600
| – | – | 0.64% | 51 |
|
|
2021
Q1 | $1.91M | Sell |
39,600
-5,000
| -11% | -$260K | 0.72% | 46 |
|
|
2020
Q4 | $2.4M | Hold |
44,600
| – | – | 0.94% | 36 |
|
|
2020
Q3 | $1.65M | Sell |
44,600
-5,000
| -10% | -$186K | 0.67% | 49 |
|
|
2020
Q2 | $1.54M | Hold |
49,600
| – | – | 0.66% | 47 |
|
|
2020
Q1 | $1.37M | Hold |
49,600
| – | – | 0.68% | 46 |
|
|
2019
Q4 | $1.45M | Hold |
49,600
| – | – | 0.59% | 55 |
|
|
2019
Q3 | $948K | Hold |
49,600
| – | – | 0.42% | 66 |
|
|
2019
Q2 | $1.09M | Hold |
49,600
| – | – | 0.48% | 64 |
|
|
2019
Q1 | $1.01M | Hold |
49,600
| – | – | 0.47% | 60 |
|
|
2018
Q4 | $625K | Hold |
49,600
| – | – | 0.33% | 70 |
|
|
2018
Q3 | $761K | Sell |
49,600
-5,200
| -9% | -$71.9K | 0.35% | 69 |
|
|
2018
Q2 | $718K | Hold |
54,800
| – | – | 0.35% | 70 |
|
|
2018
Q1 | $447K | Hold |
54,800
| – | – | 0.22% | 86 |
|
|
2017
Q4 | $486K | Hold |
54,800
| – | – | 0.24% | 80 |
|
|
2017
Q3 | $610K | Hold |
54,800
| – | – | 0.32% | 71 |
|
|
2017
Q2 | $491K | Hold |
54,800
| – | – | 0.27% | 78 |
|
|
2017
Q1 | $433K | Buy |
54,800
+21,000
| +62% | +$171K | 0.24% | 83 |
|
|
2016
Q4 | $290K | Sell |
33,800
-26,200
| -44% | -$224K | 0.18% | 96 |
|
|
2016
Q3 | $494K | Hold |
60,000
| – | – | 0.31% | 75 |
|
|
2016
Q2 | $483K | Hold |
60,000
| – | – | 0.3% | 79 |
|
|
2016
Q1 | $405K | Hold |
60,000
| – | – | 0.26% | 83 |
|
|
2015
Q4 | $473K | Hold |
60,000
| – | – | 0.3% | 77 |
|
|
2015
Q3 | $344K | Hold |
60,000
| – | – | 0.23% | 87 |
|
|
2015
Q2 | $325K | Hold |
60,000
| – | – | 0.21% | 94 |
|
|
2015
Q1 | $281K | Hold |
60,000
| – | – | 0.18% | 99 |
|
|
2014
Q4 | $251K | Hold |
60,000
| – | – | 0.16% | 102 |
|
|
2014
Q3 | $313K | Hold |
60,000
| – | – | 0.21% | 87 |
|
|
2014
Q2 | $200K | Hold |
60,000
| – | – | 0.13% | 107 |
|
|
2014
Q1 | $209K | Sell |
60,000
-10,000
| -14% | -$37.5K | 0.15% | 102 |
|
|
2013
Q4 | $254K | Hold |
70,000
| – | – | 0.18% | 96 |
|
|
2013
Q3 | $210K | Hold |
70,000
| – | – | 0.16% | 95 |
|
|
2013
Q2 | $279K | Buy |
+70,000
| New | +$267K | 0.21% | 87 |
|
Other funds holding NEO
KFO
Legacy Capital Partners's NEO Position: Q1 2022 in Review
Legacy Capital Partners increased its NeoGenomics (NEO) stake by 4.2% in Q1 2022, buying an estimated $34.9K and bringing the position to 41,260 shares worth $501K. The position accounts for 0.17% of the portfolio, ranked #103.
Legacy Capital Partners first reported a position in NEO in Q2 2013 and has held it in 36 quarters since. The position peaked at $2.4M in Q4 2020. 280 funds tracked by Wall St. Rank hold NEO as of Q1 2022.
- Legacy Capital Partners held 41,260 shares of NeoGenomics worth $501K as of Q1 2022.
- Legacy Capital Partners bought 1,660 NeoGenomics shares in Q1 2022, an estimated $34.9K.
- NeoGenomics made up 0.17% of Legacy Capital Partners's portfolio in Q1 2022, its #103 holding.
- Legacy Capital Partners first reported a position in NeoGenomics in Q2 2013 and has held it in 36 quarters since.
- Legacy Capital Partners's NeoGenomics position peaked at $2.4M in Q4 2020.
- 280 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2022.
Based on Legacy Capital Partners's 13F filing for Q1 2022, filed 11 Apr 2022.